Bio Green Med Solution (BGMS) Profit After Tax Growth (3y) (2013 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.32 Bn | 133.47 Bn | 2.84 Bn | 6.30% |
| 2 | Regeneron Pharmaceuticals | 86.96 Bn | 78.96 Bn | 3.93 Bn | 10.23% |
| 3 | Argenx Se | 64.99 Bn | 59.80 Bn | 1.37 Bn | 91.31% |
| 4 | Moderna | 58.01 Bn | 52.87 Bn | 52.00 Mn | 17.25% |
| 5 | Revolution Medicines | 44.24 Bn | 44.24 Bn | - | - |
| 6 | BeOne Medicines | 40.27 Bn | 35.17 Bn | 1.53 Bn | 37.89% |
| 7 | Alnylam Pharmaceuticals | 35.35 Bn | 32.04 Bn | 992.69 Mn | 37.44% |
| 8 | Royalty Pharma | 28.02 Bn | 27.18 Bn | - | -38.56% |
| 9 | Insmed | 27.39 Bn | 26.23 Bn | 358.27 Mn | 59.34% |
| 10 | Bio Green Med Solution | 5.04 Mn | 1.25 Mn | 79,000.00 | 57.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.95% |
| Mar 31, 2026 | 67.62% |
| Dec 31, 2025 | -15.24% |
| Sep 30, 2025 | 41.94% |
| Jun 30, 2025 | 33.95% |
| Mar 31, 2025 | 72.98% |
| Dec 31, 2024 | 1.12% |
| Sep 30, 2024 | 25.63% |
| Jun 30, 2024 | 14.04% |
| Mar 31, 2024 | 5.38% |
| Dec 31, 2023 | 7.06% |
| Sep 30, 2023 | -38.16% |
| Jun 30, 2023 | -36.00% |
| Mar 31, 2023 | -68.19% |
| Dec 31, 2022 | -46.92% |
| Sep 30, 2022 | -38.17% |
| Jun 30, 2022 | -36.90% |
| Mar 31, 2022 | -30.65% |
| Dec 31, 2021 | -36.81% |
| Sep 30, 2021 | -30.96% |